Leveraging Active Subspaces to Capture Epistemic Model Uncertainty in Deep Generative Models for Molecular Design
Not on the map. Why?
Abstract (arXiv)
Deep generative models have been accelerating the inverse design process in material and drug design. Unlike their counterpart property predictors in typical molecular design frameworks, generative molecular design models have seen fewer efforts on uncertainty quantification (UQ) due to computational challenges in Bayesian inference posed by their large number of parameters. In this work, we focus on the junction-tree variational autoencoder (JT-VAE), a popular model for generative molecular design, and address this issue by leveraging the low dimensional active subspace to capture the uncertainty in the model parameters. Specifically, we approximate the posterior distribution over the active subspace parameters to estimate the epistemic model uncertainty in an extremely high dimensional parameter space. The proposed UQ scheme does not require alteration of the model architecture, making it readily applicable to any pre-trained model. Our experiments demonstrate the efficacy of the AS-based UQ and its potential impact on molecular optimization by exploring the model diversity under epistemic uncertainty.
Key facts. Cited by 2 papers in the map (data through 7 Oct 2026). Builds on 23 of its 35 references that are in the map. First posted on arXiv 30 Apr 2024.
Builds on
23 of 35 references.
References · 23
- 2014Adam: A Method for Stochastic Optimizationcited by 36,960
- 2015Dropout as a Bayesian Approximation: Representing Model Uncertainty in Deep Learningcited by 4,416
- 2018The Lottery Ticket Hypothesis: Finding Sparse, Trainable Neural Networkscited by 2,250
- 2016Variational Inference: A Review for Statisticianscited by 1,466
- 2016Automatic chemical design using a data-driven continuous representation of moleculescited by 762
- 2018Junction Tree Variational Autoencoder for Molecular Graph Generationcited by 647
- 2015Weight Uncertainty in Neural Networkscited by 554
- 2021What Are Bayesian Neural Network Posteriors Really Like?cited by 307
- 2017Molecular De Novo Design through Deep Reinforcement Learningcited by 264
- 2021Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Developmentcited by 258
- 2018Optimization of Molecules via Deep Reinforcement Learningcited by 199
- 2022Sample Efficiency Matters: A Benchmark for Practical Molecular Optimizationcited by 151
11 more
- 2020Sample-Efficient Optimization in the Latent Space of Deep Generative Models via Weighted Retrainingcited by 121
- 2017Bayesian Compression for Deep Learningcited by 116
- 2018Multi-Objective De Novo Drug Design with Conditional Graph Generative Modelcited by 101
- 2019Subspace Inference for Bayesian Deep Learningcited by 94
- 2020Uncertainty Quantification Using Neural Networks for Molecular Property Predictioncited by 66
- 2021Improving black-box optimization in VAE latent space using decoder uncertaintycited by 51
- 2020Rethinking Parameter Counting in Deep Models: Effective Dimensionality Revisitedcited by 50
- 2021Layer Adaptive Node Selection in Bayesian Neural Networks: Statistical Guarantees and Implementation Detailscited by 14
- 2022Multi-Objective Latent Space Optimization of Generative Molecular Design Modelscited by 13
- 2023Learning Active Subspaces for Effective and Scalable Uncertainty Quantification in Deep Neural Networkscited by 9
- 2023Uncertainty Quantification for Molecular Property Predictions with Graph Neural Architecture Searchcited by 8
Built on by
Citing papers per year: 2024: 1; 2025: 0; 2026: 1.
2 papers.